Xenon Pharmaceuticals (XENE) Tops Q2 EPS by 3c

Xenon Pharmaceuticals (NASDAQ: XENE) reported Q2 EPS of ($1.11), $0.03 better than the analyst estimate of ($1.14).

For earnings history and earnings-related data on Xenon Pharmaceuticals (XENE) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Bonk Inc. redeems $4M in preferred stock, waives anti-dilution rights
• S&P 500 above 8,000 in 2026 now looks ambitious, Citi says